In addition to its current diabetes development project, PositiveID is actively looking to acquire, license or develop other complementary non-invasive glucose level testing products to help enhance daily diabetes management techniques. Proper diabetic care can help prevent or minimize a variety of health conditions, including blindness, kidney failure, loss of limbs, heart attack and stroke.

Scott R. Silverman, Chairman and CEO of PositiveID, stated, There are a variety of important research projects underway in the scientific community to better manage the growing epidemic of diabetes while improving the quality of diabetics ™ daily care. Diabetics should not have to prick their fingers multiple times each day. We believe alternative, non-invasive technologies should (and will) be the way of the future. We also believe that with our current development of an implantable glucose sensing RFID microchip, PositiveID can become a leader in this growing and needed market by expanding our pipeline of potential non-invasive diabetic care and treatment products.

Source: PositiveID Corporation